Annual EBITDA
-$262.53M$71.20M-37.21%
Summary
- Current Value
- As of today, NTRA annual EBITDA is -$262.53M, down -37.21% on
- Historical Performance
- NTRA annual EBITDA is up +47.63% over the past 3 years, down -26.42% over the past 5 years
- All-Time High Comparison
- NTRA annual EBITDA is currently -4616.21% below its historical high of $5.81M set on
- 3-Year Low Comparison
- NTRA annual EBITDA is +47.63% above its 3-year low of -$501.28M reached on an earlier date
- Sector Comparison
- NTRA annual EBITDA is higher than 5.30% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$262.53M | -37.2% | +47.6% | -26.4% | -1319.7% | |
| Quarterly EBITDA | -$54.60M | +45.7% | +47.3% | +50.3% | -778.9% | |
| TTM EBITDA | -$219.97M | +14.9% | +54.0% | +24.9% | -3440.4% | |
| Price | $336.71 | +103.2% | +486.8% | +192.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.31B | +35.9% | +181.2% | +489.8% | +10000.0% | |
| Annual EPS | -$1.52 | +0.3% | +72.7% | +46.3% | +0.2% | |
| $0.00 | +100.0% | +100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$208.16M | -9.3% | +62.0% | +9.4% | -173.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$191.33M | -37.2% | |
| 5Y | -$191.33M | -37.2% | |
| All | $5.81M | -4616.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$501.28M | N/A | +47.6% |
| 5Y | -$501.28M | +47.6% | |
| All | -$501.28M | +47.6% |
EBITDA History
FAQ
- What is the current annual EBITDA of NTRA?
- As of today, NTRA annual EBITDA is -$262.53M
- What is 1-year change in NTRA annual EBITDA?
- NTRA annual EBITDA is down -37.21% year-over-year
- What is 3-year change in NTRA annual EBITDA?
- NTRA annual EBITDA is up +47.63% over the past 3 years
- How far is NTRA annual EBITDA from its all-time high?
- NTRA annual EBITDA is currently -4616.21% below its historical high of $5.81M set on December 31, 2014
- How does NTRA annual EBITDA rank versus sector peers?
- NTRA annual EBITDA is higher than 5.30% of companies in Healthcare sector
- When is NTRA next annual earnings release?
- As of today, the next annual earnings release for NTRA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$54.60M$18.69M+25.50%
Summary
- Current Value
- As of today, NTRA quarterly EBITDA is -$54.60M, up +25.50% on
- Historical Performance
- NTRA quarterly EBITDA is up +45.67% year-over-year, up +47.32% over the past 3 years
- All-Time High Comparison
- NTRA quarterly EBITDA is currently -989.17% below its historical high of $6.14M set on
- 3-Year Low Comparison
- NTRA quarterly EBITDA is +47.32% above its 3-year low of -$103.66M reached on an earlier date
- Sector Comparison
- NTRA quarterly EBITDA is higher than 8.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$54.60M | +25.5% | +45.7% | +47.3% | +50.3% | |
| Annual EBITDA | -$262.53M | – | -37.2% | +47.6% | -26.4% | |
| TTM EBITDA | -$219.97M | +17.3% | +14.9% | +54.0% | +24.9% | |
| Price | $336.71 | +67.6% | +103.2% | +486.8% | +192.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $752.75M | +8.1% | +37.7% | +188.0% | +430.0% | |
| Quarterly EPS | -$0.47 | +22.3% | +36.9% | +52.0% | +64.5% | |
| -$75.79M | +18.9% | +31.3% | +32.6% | +34.3% | ||
| Quarterly Net Income | -$66.97M | +21.3% | +33.6% | +39.6% | +42.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$4.79M | -1040.2% | |
| 3Y | -$4.79M | -1040.2% | |
| 5Y | -$4.79M | -1040.2% | |
| All | $6.14M | -989.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$100.51M | N/A | +45.7% |
| 3Y | -$103.66M | N/A | +47.3% |
| 5Y | -$144.45M | +62.2% | |
| All | -$144.45M | +62.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of NTRA?
- As of today, NTRA quarterly EBITDA is -$54.60M
- What is NTRA quarterly EBITDA most recent change?
- NTRA quarterly EBITDA was up +25.50% on June 30, 2026
- What is 1-year change in NTRA quarterly EBITDA?
- NTRA quarterly EBITDA is up +45.67% year-over-year
- How far is NTRA quarterly EBITDA from its all-time high?
- NTRA quarterly EBITDA is currently -989.17% below its historical high of $6.14M set on September 30, 2014
- How does NTRA quarterly EBITDA rank versus sector peers?
- NTRA quarterly EBITDA is higher than 8.36% of companies in Healthcare sector
- When is NTRA next earnings release?
- The next earnings release for NTRA is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$219.97M$45.91M+17.27%
Summary
- Current Value
- As of today, NTRA TTM EBITDA is -$219.97M, up +17.27% on
- Historical Performance
- NTRA TTM EBITDA is up +14.92% year-over-year, up +53.95% over the past 3 years
- All-Time High Comparison
- NTRA TTM EBITDA is currently -14392.85% below its historical high of $1.54M set on
- 3-Year Low Comparison
- NTRA TTM EBITDA is +53.95% above its 3-year low of -$477.71M reached on an earlier date
- Sector Comparison
- NTRA TTM EBITDA is higher than 6.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$219.97M | +17.3% | +14.9% | +54.0% | +24.9% | |
| Annual EBITDA | -$262.53M | – | -37.2% | +47.6% | -26.4% | |
| Quarterly EBITDA | -$54.60M | +25.5% | +45.7% | +47.3% | +50.3% | |
| Price | $336.71 | +67.6% | +103.2% | +486.8% | +192.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.71B | +8.2% | +37.8% | +190.8% | +436.2% | |
| TTM EPS | -$1.37 | +16.6% | +28.0% | +71.6% | +62.6% | |
| -$285.77M | +10.8% | +2.7% | +44.1% | +7.2% | ||
| TTM Net Income | -$192.35M | +15.0% | +24.1% | +62.4% | +38.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$219.97M | at high | |
| 3Y | -$187.73M | -17.2% | |
| 5Y | -$187.73M | -17.2% | |
| All | $1.54M | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$314.69M | +30.1% | |
| 3Y | -$477.71M | N/A | +54.0% |
| 5Y | -$547.05M | +59.8% | |
| All | -$547.05M | +59.8% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of NTRA?
- As of today, NTRA TTM EBITDA is -$219.97M
- What is NTRA TTM EBITDA most recent change?
- NTRA TTM EBITDA was up +17.27% on June 30, 2026
- What is 1-year change in NTRA TTM EBITDA?
- NTRA TTM EBITDA is up +14.92% year-over-year
- How far is NTRA TTM EBITDA from its all-time high?
- NTRA TTM EBITDA is currently -14392.85% below its historical high of $1.54M set on March 31, 2015
- How does NTRA TTM EBITDA rank versus sector peers?
- NTRA TTM EBITDA is higher than 6.74% of companies in Healthcare sector
- When is NTRA next earnings release?
- The next earnings release for NTRA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- NTRA Official Website www.natera.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604821/000110465926020881/0001104659-26-020881-index.htm
- NTRA Profile on Yahoo Finance finance.yahoo.com/quote/NTRA
- NTRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntra